RSS Feeds
Search

Companies

CIS Pharma - Chemisches Institut Schaefer AG, Switzerland

CIS Pharma - Chemisches Institut Schaefer AG, Switzerland
Drug Delivery Systems and Medical Devices Research

The company in detail

Profile

CIS Pharma is a pharmaceutical research company specialised in drug delivery. We develop novel treatments in the fields of ophthalmology and dermatology. Our headquarter is found in Bubendorf near Basel, Switzerland.

Applying innovative chemistry CIS Pharma develops novel, target-specific treatments to improve patient care and address unmet medical needs.

Partnering strategy/interests

CIS Pharma offers licenses for the development, manufacturing and distribution of our innovations.

With regards to Cellophil we are looking for partners with a strong polymer development and sales platform. We provide cGMP-manufacturing of monomers as well as regulatory support for DMF filing. The offered Cellophil biomedical polymer technology has a wide range of applications. Our vision is to set a new gold standard in the field of biomedical polymers within the next 5 years.

Out-licensing

Cellophil™ Biomedical Polymers - New and superior biomedical polymers for drug delivery and new standards in the medical device industry
Cellophil™ is a platform of novel polymers based on amino-acid groups. The platform polymers show superior biocompatibility and can be loaded with drugs for controlled release. More

R&D

To view this information, you must subscribe to Pharmalicensing Intelligence.

Partnerships

To view this information, you must subscribe to Pharmalicensing Intelligence.

Press Releases

Frost & Sullivan Award Highlights CIS Pharma’s Technology Innovation in Polymer Industry -- Award Recipient Recognised for its Innovative and Unique Cellophil
(12th Apr 2012) London UK, 11 April 2012 - Based on its recent analysis of the responsive polymer for bio-medical application market, Frost & Sullivan recognises CIS Pharma with the 2011 European Frost & Sullivan Technology Innovation Award for its unique Cellophil™ bio- More
More press releases

Senior management

To view this information, you must subscribe to Pharmalicensing Intelligence.

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us